Unionview LLC’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$396K Buy
8,272
+110
+1% +$5.52K 0.29% 50
2024
Q3
$431K Sell
8,162
-571
-7% -$29K 0.34% 48
2024
Q2
$432K Buy
8,733
+74
+0.9% +$3.68K 0.35% 49
2024
Q1
$434K Buy
8,659
+45
+0.5% +$2.17K 0.36% 48
2023
Q4
$413K Sell
8,614
-130
-1% -$5.82K 0.37% 45
2023
Q3
$382K Buy
8,744
+53
+0.6% +$2.42K 0.36% 47
2023
Q2
$401K Sell
8,691
-21
-0.2% -$966 0.37% 48
2023
Q1
$394K Buy
8,712
+812
+10% +$36.2K 0.37% 50
2022
Q4
$332K Sell
7,900
-527
-6% -$21.3K 0.33% 56
2022
Q3
$306K Sell
8,427
-2,377
-22% -$96.9K 0.35% 54
2022
Q2
$441K Sell
10,804
-32
-0.3% -$1.42K 0.49% 43
2022
Q1
$520K Buy
10,836
+2,347
+28% +$114K 0.49% 41
2021
Q4
$433K Buy
+8,489
New +$436K 0.4% 47

Other funds holding VEA

Unionview LLC's VEA Position: Q4 2024 in Review

Unionview LLC increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 1.3% in Q4 2024, buying an estimated $5.52K and bringing the position to 8,272 shares worth $396K. The position accounts for 0.29% of the portfolio, ranked #50.

Unionview LLC first reported a position in VEA in Q4 2021 and has held it in 13 quarters since. The position peaked at $520K in Q1 2022. 2,403 funds tracked by Wall St. Rank hold VEA as of Q4 2024.

  • Unionview LLC held 8,272 shares of Vanguard FTSE Developed Markets ETF worth $396K as of Q4 2024.
  • Unionview LLC bought 110 Vanguard FTSE Developed Markets ETF shares in Q4 2024, an estimated $5.52K.
  • Vanguard FTSE Developed Markets ETF made up 0.29% of Unionview LLC's portfolio in Q4 2024, its #50 holding.
  • Unionview LLC first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2021 and has held it in 13 quarters since.
  • Unionview LLC's Vanguard FTSE Developed Markets ETF position peaked at $520K in Q1 2022.
  • 2,403 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.